Home Tags Hemab Therapeutics

Tag: Hemab Therapeutics

United States-Denmark Clinical-Stage Bleeding Disorder Biotech Company Hemab Therapeutics Nasdaq IPO...

0
United States-Denmark Clinical-Stage Bleeding Disorder Biotech Company Hemab Therapeutics Nasdaq IPO Share Price Increased +88.9% on Day 1 Trading (1/5/26: IPO Price: $18, Closing...

United States-Denmark Clinical-Stage Bleeding Disorder Biotech Company Hemab Therapeutics Nasdaq IPO...

0
United States-Denmark Clinical-Stage Bleeding Disorder Biotech Company Hemab Therapeutics Nasdaq IPO to Raise $301 Million at $795 Million Valuation with Expected IPO Listing on...